These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16893083)

  • 21. [Progress in the immunochemical studies of complement--including the establishment of nomenclature of complement proteins].
    Inai S
    Nihon Rinsho; 1979 May; 37(5):923-9. PubMed ID: 381722
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutants of complement component C3 cleaved by the C4-specific C1-s protease.
    Mathias P; Carrillo CJ; Zepf NE; Cooper NR; Ogata RT
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8125-9. PubMed ID: 1518837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.
    Daha MR; Van Es LA
    Immunology; 1981 May; 43(1):33-8. PubMed ID: 6166544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and characterization of the C345C/NTR domains of complement components C3 and C5.
    Thai CT; Ogata RT
    J Immunol; 2003 Dec; 171(12):6565-73. PubMed ID: 14662858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata.
    Nunn MA; Sharma A; Paesen GC; Adamson S; Lissina O; Willis AC; Nuttall PA
    J Immunol; 2005 Feb; 174(4):2084-91. PubMed ID: 15699138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
    Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
    Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new low molecular-weight protein effector of human complement from the venom of the Central Asian cobra Naja naja oxiana].
    Kozlov LV; Soliakov LS; Zinchenko AA
    Bioorg Khim; 1984 Mar; 10(3):323-32. PubMed ID: 6567467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement regulators and inhibitory proteins.
    Zipfel PF; Skerka C
    Nat Rev Immunol; 2009 Oct; 9(10):729-40. PubMed ID: 19730437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of MLV vector particles from human complement.
    Breun S; Salmons B; Günzburg WH; Baumann JG
    Biochem Biophys Res Commun; 1999 Oct; 264(1):1-5. PubMed ID: 10527830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of action and clinical importance of C3-nephritic-factor (author's transl)].
    Lanzer G; Pogglitsch H; Tilz GP
    Acta Med Austriaca; 1981; 8(1):7-13. PubMed ID: 6908995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
    Kölln J; Matzas M; Jänner N; Mix T; Klensang K; Bredehorst R; Spillner E
    Mol Immunol; 2004 May; 41(1):19-28. PubMed ID: 15140572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proteases in complement system (author's transl)].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
    [No Abstract]   [Full Text] [Related]  

  • 37. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.
    Kameyoshi Y; Matsushita M; Okada H
    Immunology; 1989 Dec; 68(4):439-44. PubMed ID: 2481641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ancient origin of the complement lectin pathway revealed by molecular cloning of mannan binding protein-associated serine protease from a urochordate, the Japanese ascidian, Halocynthia roretzi.
    Ji X; Azumi K; Sasaki M; Nonaka M
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6340-5. PubMed ID: 9177219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the active sites in decay-accelerating factor.
    Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
    J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.